When.com Web Search

  1. Ads

    related to: digoxin fab antibody treatment side effects for bladder cancer survival rate

Search results

  1. Results From The WOW.Com Content Network
  2. Digoxin immune fab - Wikipedia

    en.wikipedia.org/wiki/Digoxin_Immune_Fab

    Digoxin immune fab or digoxin-specific antibody is an antidote for overdose of digoxin. [3] It is made from immunoglobulin fragments from sheep that have already been immunized with a digoxin derivative, digoxindicarboxymethoxylamine (DDMA). Its brand names include Digibind (GlaxoSmithKline) and DigiFab (BTG plc).

  3. Digoxin toxicity - Wikipedia

    en.wikipedia.org/wiki/Digoxin_toxicity

    The primary treatment of digoxin toxicity is digoxin immune fab, which is an antibody made up of anti-digoxin immunoglobulin fragments. This antidote has been shown to be highly effective in treating life-threatening signs of digoxin toxicity such as hyperkalemia, hemodynamic instability, and arrhythmias. [11] Fab dose can be determined by two ...

  4. List of side effects of digoxin - Wikipedia

    en.wikipedia.org/.../List_of_side_effects_of_digoxin

    Digoxin may be prescribed for a child to treat heart defects. Possible side effects in children are: dysrhythmia, nausea, vomiting, a slower-than-normal heart rate and anorexia. [4] Children may demonstrate side effects if they are breastfed. Digoxin is also absorbed by the infant in utero. [5]

  5. Digoxin - Wikipedia

    en.wikipedia.org/wiki/Digoxin

    A 2008 study suggested digoxin has beneficial effects not only for the heart, but also in reducing the risk of certain kinds of cancer. [55] However, comments on this study suggested that digoxin is not effective at reducing cancer risk at therapeutic concentrations of the drug, [56] so the results need further investigation. [57]

  6. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    ovarian cancer, malignant ascites, gastric cancer cBR96-doxorubicin immunoconjugate: mab: humanized: Lewis-Y antigen: cancer Cedelizumab [47] mab: humanized: CD4: prevention of organ transplant rejections, treatment of autoimmune diseases Cemiplimab [32] Libtayo: mab: human: PD-1: Y: cutaneous squamous cell carcinoma Cergutuzumab amunaleukin ...

  7. Bladder cancer - Wikipedia

    en.wikipedia.org/wiki/Bladder_cancer

    Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2] This makes bladder cancer the sixth most common cancer in men, and the seventeenth in women. [69] When women are diagnosed with bladder cancer, they tend to have more advanced disease and consequently a poorer prognosis. [69]